Chengxiao Fu

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Atrial Fibrillation

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

Clinical drug investigation

Drug design, development and therapy

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Xiongwen Yang, Bo Yang, Dan Li, Wei Pan, Qin Tong, Lili Wang, Danjun Chen, Chengxiao Fu
Thromboembolic Events Associated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Pharmacovigilance Analysis of the US FDA Adverse Event Reporting System (FAERS) Database. Clinical drug investigation (2024)
Xiongwen Yang, Bo Yang, Dan Li, Wei Pan, Qin Tong, Lili Wang, Danjun Chen, Chengxiao Fu
Thromboembolic Events Associated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Pharmacovigilance Analysis of the US FDA Adverse Event Reporting System (FAERS) Database. Clinical drug investigation 44 (3) (2024)
Xiongwen Yang, Bo Yang, Dan Li, Wei Pan, Qin Tong, Lili Wang, Danjun Chen, Chengxiao Fu
Thromboembolic Events Associated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Pharmacovigilance Analysis of the US FDA Adverse Event Reporting System (FAERS) Database. Clinical drug investigation 44 (3) (2024)
Chengxiao Fu, Qi Pei, Wu Liang, Bo Yang, Wei Li, Jun Liu, Hongyi Tan, Cheng-Xian Guo, Hao Zhang, Guo-Ping Yang
Population Pharmacokinetic Modelling for Nifedipine to Evaluate the Effect of Parathyroid Hormone on CYP3A in Patients with Chronic Kidney Disease. Drug design, development and therapy 16 (2022)
Jian Tang, Chengxiao Fu, Yanwen Li, Shuangqin Chen, Xiaoxin Jiang, Wenqian Xu, Haitao Xie
Long Noncoding RNA OIP5-AS1 Promotes the Disease Progression in Nasopharyngeal Carcinoma by Targeting miR-203. BioMed research international 2021 (2021)